biospecimen_aliquot__bcr_aliquot_barcode	tcga-ac-a62x-01a-11d-a29n-09
biospecimen_aliquot__bcr_aliquot_uuid	c16a9047-5cff-4096-902f-de7ceca1c349
biospecimen_aliquot__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_aliquot__bcr_sample_barcode	tcga-ac-a62x-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0145629992
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2013-05-08
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a29n
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	2.80
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ac-a62x-01a-11d
biospecimen_analyte__bcr_analyte_uuid	2ad2fb3a-6a59-4eb5-9ed1-e699924608b9
biospecimen_analyte__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_analyte__bcr_sample_barcode	tcga-ac-a62x-01a
biospecimen_analyte__concentration	0.14
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ac-a62x
biospecimen_diagnostic_slides__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ac-a62x-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	36fdc9aa-4ebe-40e6-92c2-8471049171a4
biospecimen_normal_control__bcr_patient_barcode	tcga-ac-a62x
biospecimen_normal_control__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_portion__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_portion__bcr_portion_barcode	tcga-ac-a62x-01a-11
biospecimen_portion__bcr_portion_uuid	3b6032ac-120b-42cc-96ae-626bac5d0e36
biospecimen_portion__bcr_sample_barcode	tcga-ac-a62x-01a
biospecimen_portion__date_of_creation	2013-04-11
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ac-a62x-01a-11d
biospecimen_protocol__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_protocol__bcr_sample_barcode	tcga-ac-a62x-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_sample__bcr_sample_barcode	tcga-ac-a62x-01a
biospecimen_sample__bcr_sample_uuid	5aeef496-2885-42d7-802e-319b76bbe215
biospecimen_sample__days_to_collection	70
biospecimen_sample__initial_weight	130
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-ac-a62x.6bb72835-1002-4b35-9304-495e12a30905.pdf
biospecimen_sample__pathology_report_uuid	6bb72835-1002-4b35-9304-495e12a30905
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ac-a62x-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	4956c5cb-1ab4-46c2-8df0-1d71a2a73f15
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a321
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ac-a62x-01a-21-a321-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	16
biospecimen_shipment_portion__shipment_portion_month_of_shipment	9
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2013
biospecimen_slide__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
biospecimen_slide__bcr_sample_barcode	tcga-ac-a62x-01a
biospecimen_slide__bcr_slide_barcode	tcga-ac-a62x-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	e5ad5dd0-3cd3-412a-8ee8-1491c492d2c1
biospecimen_slide__image_file_name	tcga-ac-a62x-01a-01-ts1.e5ad5dd0-3cd3-412a-8ee8-1491c492d2c1.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	40
biospecimen_slide__percent_monocyte_infiltration	20
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	20
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	20
biospecimen_slide__percent_tumor_cells	80
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ac-a62x
biospecimen_tumor_sample__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
clinical_follow_up__bcr_followup_barcode	tcga-ac-a62x-f64105
clinical_follow_up__bcr_followup_uuid	197f52a1-868a-492c-8e1b-a887ced07862
clinical_follow_up__bcr_patient_barcode	tcga-ac-a62x
clinical_follow_up__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-8-26
clinical_follow_up__last_contact_days_to	417
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_omf__bcr_omf_barcode	tcga-ac-a62x-o41792
clinical_omf__bcr_omf_uuid	8f8dd905-8b98-4db8-ab56-39960886825a
clinical_omf__bcr_patient_barcode	tcga-ac-a62x
clinical_omf__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
clinical_omf__days_to_other_malignancy_dx	-2439
clinical_omf__days_to_surgical_resection	-2430
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2013-3-27
clinical_omf__malignancy_type	prior malignancy
clinical_omf__other_malignancy_anatomic_site	breast
clinical_omf__other_malignancy_histological_type	other, specify
clinical_omf__other_malignancy_histological_type_text	ductal carcinoma in situ
clinical_omf__other_malignancy_laterality	right
clinical_omf__pathologic_M	m0
clinical_omf__pathologic_N	n0
clinical_omf__pathologic_T	tis (dcis)
clinical_omf__pathologic_stage	stage 0is
clinical_omf__radiation_tx_indicator	no
clinical_omf__surgery_indicator	yes
clinical_omf__surgery_type	resection
clinical_omf__system_version	6th
clinical_patient__age_at_diagnosis	72
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-ac-a62x
clinical_patient__bcr_patient_uuid	5b2a4f11-ca46-4974-9420-59b4820920bf
clinical_patient__birth_days_to	-26627
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	<10%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2013-10-21
clinical_patient__gender	female
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2013
clinical_patient__last_contact_days_to	34
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	10
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__new_tumor_event_dx_indicator	no
clinical_patient__patient_id	a62x
clinical_patient__pr_status_by_ihc	negative
clinical_patient__prospective_collection	yes
clinical_patient__race	black or african american
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ac
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AC-A62X-01A-11D-A29N-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AC-A62X-01A-11D-A29N-09.bed.meta
manually_curated__id	tcga-ac-a62x-01a-11d-a29n-09
manually_curated__md5sum	6abd89844d8c9e2dcda0e44db3aa8a0e
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	c16a9047-5cff-4096-902f-de7ceca1c349
manually_curated__tumor_tag	brca
